These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4302017)

  • 21. Primary targets for photoinactivation of vesicular stomatitis virus by AIPcS4 or Pc4 and red light.
    Moor AC; Wagenaars-van Gompel AE; Brand A; Dubbelman MA; VanSteveninck J
    Photochem Photobiol; 1997 Mar; 65(3):465-70. PubMed ID: 9077133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein.
    Stauffer F; De Miranda J; Schechter MC; Carneiro FA; Salgado LT; Machado GF; Da Poian AT
    Antiviral Res; 2007 Jan; 73(1):31-9. PubMed ID: 16934341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of various steps in the replication cycle of vesicular stomatitis virus contributes to its photoinactivation by AlPcS4 or Pc4 and red light.
    Moor AC; Wagenaars-van Gompel AE; Hermanns RC; van der Meulen J; Smit J; Wilschut J; Brand A; Dubbelman TM; VanSteveninck J
    Photochem Photobiol; 1999 Mar; 69(3):353-9. PubMed ID: 10089828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of enveloped viruses by singlet oxygen thermally generated from a polymeric naphthalene derivative.
    Käsermann F; Kempf C
    Antiviral Res; 1998 Apr; 38(1):55-62. PubMed ID: 9614004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of protein synthesis in L cells infected with vesicular stomatitis virus.
    Wertz GW; Youngner JS
    J Virol; 1972 Jan; 9(1):85-9. PubMed ID: 4333546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infective virus substructure from vesicular stomatitis virus.
    Brown F; Cartwright B; Crick J; Smale CJ
    J Virol; 1967 Apr; 1(2):368-73. PubMed ID: 4318952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation by gamma irradiation of animal viruses in simulated laboratory effluent.
    Thomas FC; Ouwerkerk T; McKercher P
    Appl Environ Microbiol; 1982 May; 43(5):1051-6. PubMed ID: 6285822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of vesicular stomatitis virus by disinfectants.
    Wright HS
    Appl Microbiol; 1970 Jan; 19(1):96-9. PubMed ID: 4313317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of U.v.-irradiated vesicular stomatitis virus on nucleic acid synthesis in chick embryo cells.
    Yaoi Y; Mitsui H; Amano M
    J Gen Virol; 1970 Sep; 8(3):165-72. PubMed ID: 4321565
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of the virion-associated RNA polymerase of vesicular stomatitis virus by melittin.
    Roy J; Chanda PK; Thornton GB; Luk D; Banerjee AK
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1265-71. PubMed ID: 6285902
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin E.
    Ben-Hur E; Rywkin S; Rosenthal I; Geacintov NE; Horowitz B
    Transfusion; 1995 May; 35(5):401-6. PubMed ID: 7740611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus.
    Zimmer B; Summermatter K; Zimmer G
    Vet Microbiol; 2013 Feb; 162(1):78-84. PubMed ID: 22995872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether.
    Brown F; Cartwright B; Smale CJ
    J Immunol; 1967 Jul; 99(1):171-7. PubMed ID: 4291443
    [No Abstract]   [Full Text] [Related]  

  • 35. Mode of action of acid pH values on the development of vesicular stomatitis virus.
    Fiszman M; Leaute JB; Chany C; Girard M
    J Virol; 1974 Apr; 13(4):801-8. PubMed ID: 4132389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid.
    Schloemer RH; Wagner RR
    J Virol; 1975 Apr; 15(4):882-93. PubMed ID: 163924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 38. Low infectivity of vesicular stomatitis virus (VSV) particles released from interferon-treated cells is related to glycoprotein deficiency.
    Maheshwari RK; Husain MM; Friedman RM
    Biochem Biophys Res Commun; 1983 Nov; 117(1):161-8. PubMed ID: 6318745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Order of transcription of genes of vesicular stomatitis virus.
    Ball LA; White CN
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):442-6. PubMed ID: 174107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electron microscopic observations of vesicular stomatitis virus particles penetration in human fibroblasts.
    Cernescu C; Constantinescu SN; Popescu LM
    Rev Roum Virol; 1990; 41(2):93-6. PubMed ID: 2176536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.